Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew R Haas

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 14, 2010
A phase I trial of repeated intrapleural adenoviral-mediated interferon-beta gene transfer for mesothelioma and metastatic pleural effusionsDaniel H Sterman, Adri Recio, Andrew R Haas, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 19, 2018
Phase I Study of Intrapleural Gene-Mediated Cytotoxic Immunotherapy in Patients with Malignant Pleural EffusionCharu Aggarwal, Andrew R Haas, Susan Metzger, et al.
Journal of Thoracic Disease|September 22, 2017
The value of delayed phase enhanced imaging in malignant pleural mesotheliomaAkash M Patel, Ian Berger, E Paul Wileyto, et al.
Annals of Surgery|June 17, 2020
Outcomes After Tracheostomy in COVID-19 PatientsTiffany N Chao, Sean P Harbison, Benjamin M Braslow, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 7, 2020
Neoadjuvant Gene-Mediated Cytotoxic Immunotherapy for Non-Small-Cell Lung Cancer: Safety and Immunologic ActivityJarrod D Predina, Andrew R Haas, Marina Martinez, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 18, 2019
Phase I Study of Lentiviral-Transduced Chimeric Antigen Receptor-Modified T Cells Recognizing Mesothelin in Advanced Solid CancersAndrew R Haas, Janos L Tanyi, Mark H O'Hara, et al.
Plos One|May 30, 2019
Molecular analysis of the endobronchial stent microbial biofilm reveals bacterial communities that associate with stent material and frequent fungal constituentsJohn E McGinniss, Ize Imai, Aurea Simon-Soro, et al.
JAMA Network Open|March 10, 2023
Clinical Outcomes Associated With Pembrolizumab Monotherapy Among Adults With Diffuse Malignant Peritoneal MesotheliomaMelina E Marmarelis, Xiao Wang, Leonid Roshkovan, et al.
JTO Clinical and Research Reports|April 8, 2022
Plasma Genotyping at the Time of Diagnostic Tissue Biopsy Decreases Time-to-Treatment in Patients With Advanced NSCLC-Results From a Prospective Pilot StudyJeffrey C Thompson, Charu Aggarwal, Janeline Wong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2016
Pilot and Feasibility Trial Evaluating Immuno-Gene Therapy of Malignant Mesothelioma Using Intrapleural Delivery of Adenovirus-IFNα Combined with ChemotherapyDaniel H Sterman, Evan Alley, James P Stevenson, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 14, 2010
A phase I trial of repeated intrapleural adenoviral-mediated interferon-beta gene transfer for mesothelioma and metastatic pleural effusionsDaniel H Sterman, Adri Recio, Andrew R Haas, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 19, 2018
Phase I Study of Intrapleural Gene-Mediated Cytotoxic Immunotherapy in Patients with Malignant Pleural EffusionCharu Aggarwal, Andrew R Haas, Susan Metzger, et al.
Journal of Thoracic Disease|September 22, 2017
The value of delayed phase enhanced imaging in malignant pleural mesotheliomaAkash M Patel, Ian Berger, E Paul Wileyto, et al.
Annals of Surgery|June 17, 2020
Outcomes After Tracheostomy in COVID-19 PatientsTiffany N Chao, Sean P Harbison, Benjamin M Braslow, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 7, 2020
Neoadjuvant Gene-Mediated Cytotoxic Immunotherapy for Non-Small-Cell Lung Cancer: Safety and Immunologic ActivityJarrod D Predina, Andrew R Haas, Marina Martinez, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 18, 2019
Phase I Study of Lentiviral-Transduced Chimeric Antigen Receptor-Modified T Cells Recognizing Mesothelin in Advanced Solid CancersAndrew R Haas, Janos L Tanyi, Mark H O'Hara, et al.
Plos One|May 30, 2019
Molecular analysis of the endobronchial stent microbial biofilm reveals bacterial communities that associate with stent material and frequent fungal constituentsJohn E McGinniss, Ize Imai, Aurea Simon-Soro, et al.
JAMA Network Open|March 10, 2023
Clinical Outcomes Associated With Pembrolizumab Monotherapy Among Adults With Diffuse Malignant Peritoneal MesotheliomaMelina E Marmarelis, Xiao Wang, Leonid Roshkovan, et al.
JTO Clinical and Research Reports|April 8, 2022
Plasma Genotyping at the Time of Diagnostic Tissue Biopsy Decreases Time-to-Treatment in Patients With Advanced NSCLC-Results From a Prospective Pilot StudyJeffrey C Thompson, Charu Aggarwal, Janeline Wong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2016
Pilot and Feasibility Trial Evaluating Immuno-Gene Therapy of Malignant Mesothelioma Using Intrapleural Delivery of Adenovirus-IFNα Combined with ChemotherapyDaniel H Sterman, Evan Alley, James P Stevenson, et al.
Pageof 8